Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide and CAR-T/TCR-T for HIV Latent Reservoir
NCT03980691Phase 1Completed
- Sponsor
- Guangzhou Eighth People's Hospital
- Start
- Dec 2017
- Primary completion
- May 2020
- Modality
- Gene Editing, Gene Silencing, CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of tucidinostat, ISIKOK-19 and TCR-T cell therapy (Guangzhou 8th People's Hospital) in human immunodeficiency virus infection (HIV), sponsored by Guangzhou Eighth People's Hospital. Started Dec 2017; status: completed.
02
Drugs
tucidinostatISIKOK-19TCR-T cell therapy (Guangzhou 8th People's Hospital)
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03980691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03980691.